German AF GAF686 Global Explorer departed Koln/Bonn Airport se to Innsbruck, Austria Airport for several fly overs and sw towards the Azores currently
good morning baker
2-RNWL UK Military Contractor Citationjet M2 se from Cannes Airport, France
2 registration for masked or private owner
RAF MARIA G5 departed Farnborough Airport (se of London) and se
VENUS44 USAF G5 ne from JBA
R50338 US Army Dash 8 out of Manassas, VA sw
PAT009 US Army C-560 on final at JBA from Syracuse-Hancock Int'l Airport, NY
US Navy P-8 Poseidens (and a P-3 Orion VVLL12 heading south) out of NAS jax-moar than normal
VVLL875 169342 168428 VVLL857 VVLL868 P-8's
Icahn sells over $700 million worth of Herbalife stock, but remains largest shareholder
Shares of Herbalife Nutrition Ltd. HLF, -1.17% fell 2.1% in morning trading Wednesday, after billionaire activist investor Carl Icahn said his Icahn Enterprises L.P. IEP, 1.08% sold 14.7 million of the nutritional supplements company's shares, which reduced its stake in the company by about 42%. Icahn said the stock sale was part of Herbalife's self-tender offer, in which it accepts to buy back up to $750 million worth of its shares at $48.75 each. At that price, the 14.7 million shares Icahn sold would be valued at $716.6 million. Icahn Enterprises' stock rose 1.3% in morning trading. Icahn remains Herbalife's largest shareholder with about 20.5 million shares, or 15.5% of the shares outstanding. Herbalife's stock has dropped 8.6% amid a four-day losing streak, since it closed at a 14-month high of $52.63 on Aug. 6. The stock has gained 0.8% year to date, while the S&P 500 SPX, 1.10% has tacked on 4.3%.
https://www.marketwatch.com/story/icahn-sells-over-700-million-worth-of-herbalife-stock-but-remains-largest-shareholder-2020-08-12
Kodak raised spending on lobbying government in months before loan awarded
Kodak previously spent barely any money on lobbying. Eastman Kodak Co increased spending on lobbying the U.S. government in the months before the Trump administration announced a $765 million loan to the photographic equipment maker, public disclosures filed with the Congress show.
The company spent $870,000 as "expense relating to lobbying activities" from April through June, according to the lobbying disclosures. Kodak had previously not spent any money on lobbying since an expense of less than $5,000 in the first quarter of 2019.
The company insisted it raised lobbying expenses while exploring support from the government due to the coronavirus outbreak. “With the onset of COVID-19, Kodak, like many businesses across the country, explored federal support for the company and our workers, as well as opportunities to assist the government, on the state and federal level, in response to the pandemic,” a company spokesman said in an emailed statement.
“This included our application for a federal loan to support the launch of Kodak Pharmaceuticals with the intent to bolster the domestic response to COVID-19”, the statement added. The increase in Kodak’s lobbying efforts was reported earlier by Bloomberg.
Kodak’s $765 million loan agreement with the U.S. government to produce pharmaceutical ingredients was put on hold on Friday due to “recent allegations of wrongdoing”.
Last week, senior Democratic lawmakers asked federal regulators to investigate securities transactions made by the company and its executives around the time it learned it could receive the loan. They cited concerns about insider trading. Kodak said on Tuesday investigations by Congress and the Securities Exchange Commission have commenced, and could impact the loan’s outcome.
The company also said it expects sales volumes and working capital to improve in the current quarter after reporting a 31% decline in quarterly revenue due to the pandemic.
https://www.foxbusiness.com/markets/kodak-stock-investigation-lobbying-government
o7